PPARG and obesity due to melanocortin 4 receptor deficiency: Additionally, the use of hASCs has enabled the discovery of Thymoquinone’s ability to hinder adipocyte differentiation by suppressing PPARγ and FAS protein expression, positioning it as a promising anti-obesity compound [12].